Sotac Pharmaceuticals Limited — Others, 25-06-2025: Disclosure under SEBI Takeover Regulations

Sharadkumar Dashrathbhai Patel, promoter of Sotac Pharmaceuticals, has confirmed that neither he nor the promoter group or persons acting in concert have created any new encumbrances on their shareholdings during the financial year 2024-25 beyond those already disclosed. This declaration assures shareholders and stakeholders of the promoter group's unencumbered stake in the company, reflecting stability and no additional lien risks on promoter-held shares. The promoter group includes 71 individuals and entities closely associated with the company’s management and operations.